Children’s Tumor Foundation (CTF): Clinical Research Award (CRA)

Supports early stage pilot clinical trials of candidate therapeutics, or interventions for treatment of physical or psychosocial manifestations of NF1, NF2, and schwannomatosis. This grant mechanism also includes adjunct studies, such as the development of biomarkers, imaging protocols, and other clinical trial tools. Funding: up to $150,000 (including indirect costs) per year for 18-24 months.

http://www.ctf.org/CTF-Young-Investigator-Award/Guidelines.html